Literature DB >> 6616417

Myelopathy with severe structural derangement associated with combined modality therapy.

M E Cohen, P K Duffner, K L Terplan.   

Abstract

Myelopathy is a known complication of radiation therapy, but its association with chemotherapy has been less well documented. The authors report the case of a 12-year-old boy with medulloblastoma who had been followed for an 8 1/2-year period. In the context of accepted doses of intrathecal methotrexate and spinal irradiation, he developed an extensive myelopathy. At postmortem he was found to have profound fibrosis of the leptomeninges and necrosis with structural derangement of the spinal cord. It is speculated that these findings are secondary to a combination of radiation acting in synergism with methotrexate. The pertinent literature relating to myelopathy associated with radiation and chemotherapy is reviewed.

Entities:  

Mesh:

Year:  1983        PMID: 6616417     DOI: 10.1002/1097-0142(19831101)52:9<1590::aid-cncr2820520909>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.

Authors:  C R Thomas; K J Stelzer; J G Douglas; W J Koh; L V Wood; R Panicker
Journal:  J Natl Med Assoc       Date:  1994-11       Impact factor: 1.798

2.  Radiation Myelopathy Caused by Palliative Radiotherapy and Intrathecal Methotrexate.

Authors:  Yukiko Fukuda; Satoru Takahashi; Michiko Nakamura; Masashi Endo; Kazunari Ogawa; Masahiro Kawahara; Keiko Akahane; Shoko Ito; Yoshinobu Kanda; Harushi Mori; Katsuyuki Shirai
Journal:  Case Rep Oncol       Date:  2022-07-01

3.  Radiation Therapy for Young Children Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant for Primary Brain Tumors.

Authors:  Sarah A Milgrom; Jane Koo; Nicholas Foreman; Arthur K Liu; Kristen Campbell; Kathleen Dorris; Adam L Green; Nathan Dahl; Andrew M Donson; Rajeev Vibhakar; Jean M Mulcahy Levy
Journal:  Adv Radiat Oncol       Date:  2022-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.